Wednesday 24 October |
Indigovision |
Beeks Financial |
Redde |
Photo-Me International |
Thursday 25 October |
Green & Smart Holdings |
Filtronic |
Goldplat |
1pm |
South32 |
Octagonal |
Mattioli Woods |
Alumasc Group |
Friday 26 October |
Argos Resources |
Springfield Properties |
Paternoster Resources |
K3 Capital Group |
Monday 29 October |
ITM Power |
Tuesday 30 October |
Accrol Group |
Angle |
Hargreaves Services |
Scancell Holdings |
Randall & Quilter |
Ideagen |
Scancell gets go-ahead for UK second phase trials of 'SCIB1'
(Sharecast News) - Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of 'SCIB1' in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.
Read more